Achilles Therapeutics plc
ACHL
Price:
$0.7199
Market Cap:
$29.58M
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therap...[Read more]
Industry
Biotechnology
IPO Date
2021-03-31
Stock Exchange
NASDAQ
Ticker
ACHL
The ROE as of September 2024 (TTM) for Achilles Therapeutics plc (ACHL) is -47.36%
According to Achilles Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is -47.36%. This represents a change of 297.35% compared to the average of -11.92% of the last 4 quarters.
Achilles Therapeutics plc (ACHL) Historical ROE (quarterly & annually)
How has ACHL ROE performed in the past?
The mean historical ROE of Achilles Therapeutics plc over the last ten years is -32.00%. The current -47.36% ROE has changed 47.99% with respect to the historical average. Over the past ten years (40 quarters), ACHL's ROE was at its highest in in the September 2021 quarter at -4.24%. The ROE was at its lowest in in the March 2019 quarter at -27.95%.
Average
-32.00%
Median
-28.61%
Minimum
-54.34%
Maximum
-13.80%
Achilles Therapeutics plc (ACHL) ROE by Quarter and Year
Discovering the peaks and valleys of Achilles Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.17%
Maximum Annual ROE = -13.80%
Minimum Annual Increase = -74.60%
Minimum Annual ROE = -54.34%
| Year | ROE | Change |
|---|---|---|
| 2023 | -49.12% | 35.99% |
| 2022 | -36.12% | 71.17% |
| 2021 | -21.10% | 20.37% |
| 2020 | -17.53% | 27.00% |
| 2019 | -13.80% | -74.60% |
Achilles Therapeutics plc (ACHL) Average ROE
How has ACHL ROE performed in the past?
The current ROE of Achilles Therapeutics plc (ACHL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-35.45%
5-year avg
-27.54%
10-year avg
-32.00%
Achilles Therapeutics plc (ACHL) ROE vs. Peers
How is ACHL’s ROE compared to its peers?
Achilles Therapeutics plc’s ROE is greater than Assembly Biosciences, Inc. (-121.55%), less than Spero Therapeutics, Inc. (20.70%), greater than Instil Bio, Inc. (-55.57%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Nuvation Bio Inc. (-98.79%), greater than CytomX Therapeutics, Inc. (-27.44%), greater than NextCure, Inc. (-57.63%),
| Company | ROE | Market cap |
|---|---|---|
| -121.55% | $107.81M | |
| 20.70% | $71.07M | |
| -55.57% | $92.68M | |
| -47.64% | $8.20M | |
| -98.79% | $692.60M | |
| -27.44% | $93.74M | |
| -57.63% | $39.73M |
Build a custom stock screener for Achilles Therapeutics plc (ACHL) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achilles Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Achilles Therapeutics plc (ACHL) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Achilles Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Achilles Therapeutics plc's ROE?
How is the ROE calculated for Achilles Therapeutics plc (ACHL)?
What is the highest ROE for Achilles Therapeutics plc (ACHL)?
What is the 3-year average ROE for Achilles Therapeutics plc (ACHL)?
What is the 5-year average ROE for Achilles Therapeutics plc (ACHL)?
How does the current ROE for Achilles Therapeutics plc (ACHL) compare to its historical average?